CADESS.AI was spun out from Uppsala University in 2016 with the mission to improve patient outcome and reduce healthcare costs for prostate cancer by delivering innovative digital pathology decision support solutions. The company is headquartered in Uppsala, Sweden, but has operated since the beginning of 2021 from New Jersey in the USA.
CADESS™ is an AI-based decision support system for hospital and commercial pathology laboratories involved in diagnosis and prognostication of prostate cancer. CADESS™ is based on state-of-the-art deep learning and imaging analysis technology, offering improved diagnostic accuracy resulting in reduced patient suffering and lower treatment costs.
Company’s Keywords:
digital pathology, prostate cancer, artificial inteligence, deep learning, image analysis
<1
<
<2016
Your request has been submitted successfully.
Own or work here?